 PPS: Physician CMEPrimary Format :
Language :
Also Listed as:
City : State/Province : Country : Country : User Tags:
User Votes:
RSS Feed Website
People found this Podcast
Searching for:
View this Podcast on a Google Map. 

Text Only listing of Clinical Insights™ in Diabetes Podcasts
Trumix.com listings of Clinical Insights™ in Diabetes Podcasts
Click Here to Update the directory of this podcasts programs.
If you like this podcast, you might also like:
|
February 2008 Audio - Volume 11, Number 2
Sex-Specific General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study; Intensified Multifactorial Intervention Reduces Mortality in Type 2 Diabetes; Commentary by Henry N. Ginsberg, MDListen | Listen in your iPhone | Download | View full cache | Visit Website February 2008 PDF Course Materials - Volume 11, Number 2Sex-Specific General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study; Intensified Multifactorial Intervention Reduces Mortality in Type 2 Diabetes; Commentary by Henry N. Ginsberg, MDListen | Listen in your iPhone | Download | View full cache | Visit Website January 2008 Audio - Volume 11, Number 1A Meta-analysis of the Effects of Therapy With Inhibitors of the Renin-Angiotensin System on Proteinuria in Patients With Renal Disease; Gastric Banding Leads to Type 2 Diabetes Remission in Obese Patients; Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction; Commentary by Vivian Fonseca, MDListen | Listen in your iPhone | Download | View full cache | Visit Website January 2008 PDF Course Materials - Volume 11, Number 1A Meta-analysis of the Effects of Therapy With Inhibitors of the Renin-Angiotensin System on Proteinuria in Patients With Renal Disease; Gastric Banding Leads to Type 2 Diabetes Remission in Obese Patients; Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction; Commentary by Vivian Fonseca, MDListen | Listen in your iPhone | Download | View full cache | Visit Website March 2008 Audio - Volume 11, Number 3Meta-Analysis of Efficacy of Statin Therapy in 18,686 Patients With Diabetes From 14 Randomized Trials; Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee; The Impact of Intrauterine Hyperglycemia on the High Prevalence of Type 2 Diabetes and Pre-Diabetes in Adult Offspring of Women With Type 1 Diabetes or Gestational Diabetes Mellitus; Commentary by James W. Reed, MDListen | Listen in your iPhone | Download | View full cache | Visit Website March 2008 PDF Course Materials - Volume 11, Number 3Meta-Analysis of Efficacy of Statin Therapy in 18,686 Patients With Diabetes From 14 Randomized Trials; Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee; The Impact of Intrauterine Hyperglycemia on the High Prevalence of Type 2 Diabetes and Pre-Diabetes in Adult Offspring of Women With Type 1 Diabetes or Gestational Diabetes Mellitus; Commentary by James W. Reed, MDListen | Listen in your iPhone | Download | View full cache | Visit Website August 2007 PDF Course Materials - Volume 10, Number 8Diabetic Retinopathy and the Risk of Coronary Heart Disease: The ARIC Study; Incretin Levels and Effect Are Markedly Enhanced 1 Month After Roux-en-Y Gastric Bypass Surgery in Obese Patients With Type 2 Diabetes; No Impact on All-Cause Mortality With Various Oral Antihyperglycemic Agents Relative to Sulfonylurea; Commentary by Bernard Zinman, MDListen | Listen in your iPhone | Download | View full cache | Visit Website July 2007 PDF Course Materials - Volume 10, Number 7Intentional Weight Loss Improves Cardiovascular Disease Risk Factors in Type 2 Diabetes; Very Low Birth Weight Is Associated With Impaired Glucose
Regulation in Young Adults; Commentary by Vivian A. Fonseca, MD; Type 2 Diabetes and Life Expectancy With and Without Cardiovascular DiseaseListen | Listen in your iPhone | Download | View full cache | Visit Website July 2007 PDF Course Materials - Volume 10, Number 6Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death From Cardiovascular Causes; Topiramate Controlled Release in the Treatment of Obese Patients With Type 2 Diabetes; An Interim Analysis of Cardiovascular Outcomes With Rosiglitazone: The RECORD Trial; Commentary by Burton E. Sobel, MD and John B. Buse, MD, PhDListen | Listen in your iPhone | Download | View full cache | Visit Website May 2007 PDF Course Materials - Volume 10, Number 5Addition of Exenatide to Thiazolidinedione Therapy Improves Glycemic Control and Reduces Body Weight in Patients With Type 2 Diabetes; Disparities in Insulin Resistance and Risk Factors for Type 2 Diabetes and Cardiovascular Disease in Moderately Obese Individuals; Traditional Obesity Theshold Might Be Too High for Non-European Populations; Commentary by Thomas A. Buchanan, MDListen | Listen in your iPhone | Download | View full cache | Visit Website April 2007 PDF Course Materials - Volume 10, Number 4American Diabetes Association Consensus Statement on IFG and IGT; Rosuvastatin Decreases Progression of Carotid Intima-Media Thickness in Patients With Subclinical Atherosclerosis but Does Not Induce Regression; Boric Acid Vaginal Suppositories Are More Effective Than Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis; Commentary by Saul Genuth, MDListen | Listen in your iPhone | Download | View full cache | Visit Website March 2007 PDF Course Materials - Volume 10, Number 3Rate of Progression From Impaired Fasting Glucose to Type 2 Diabetes Effects of Pioglitazone on Risk of Stroke in Patients With
Type 2 Diabetes Stages in the Evolution of Type 2 Diabetes: Loss of Postprandial Glycemic Control Followed by Nocturnal Fasting Hyperglycemia
Commentary by David L. Bronson, MD
Listen | Listen in your iPhone | Download | View full cache | Visit Website February 2007 PDF Course Materials - Volume 10, Number 2Sitagliptin Improves Glycemic Control in Patients With Type 2 Diabetes Not Controlled With Either Metformin or Pioglitazone: The Results of Two Studies; Intensive Lipid-Lowering Therapy for Acute Coronary Syndrome and Diabetes Effect of Folic Acid Supplementation on Risk of CVD. Commentary by James W. Reed, MDListen | Listen in your iPhone | Download | View full cache | Visit Website January 2007 PDF Course Materials - Volume 10, Number 1AHA/ADA Statement on Primary Prevention of CVD in People With Type 2 Diabetes ADA Standards of Medical Care in Diabetes—2007 NDEI® Upcoming CME/CE Live Events Commentary by Henry N. Ginsberg, MDListen | Listen in your iPhone | Download | View full cache | Visit Website December 2006 PDF Course Materials - Volume 9, Number 12Comparing Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Therapy: The ADOPT Study; Fasting Glucose Levels and Incident Type 2 Diabetes in Older Adults Without Diabetes Receiving Antihypertensive Treatment; Asymptomatic Bacteriuria in Women With Type 2 Diabetes; Commentary by Vivian Fonseca, MDListen | Listen in your iPhone | Download | View full cache | Visit Website November 2006 PDF Course Materials - Volume 9, Number 11Effect of Pioglitazone vs Glimepiride on Carotid IMT in Type 2 Diabetes: The CHICAGO Trial Efficacy of Metformin Therapy in Nonobese Persons With Type 2 Diabetes Addition of Glargine Insulin or Rosiglitazone to Metformin Plus Sulfonylurea for Poorly Controlled Type 2 Diabetes Commentary by Bernard Zinman, MDCMListen | Listen in your iPhone | Download | View full cache | Visit Website October 2006 PDF Course Materials - Volume 9, Number 10HRosiglitazone Plus Lifestyle Changes Reduce the Incidence of Type 2 Diabetes and Increase Regression to Normoglycemia in Patients at High Risk: the DREAM Trial; Inhaled Human Insulin vs Glyburide as Adjunctive Therapy for Type 2 Diabetes; Different Lifestyles Create Significantly Different Prevalences of Type 2 Diabetes in Pima Indians in the US and Mexico; Commentaries by Thomas A. Buchanan, MD and Mayer B. Davidson, MDListen | Listen in your iPhone | Download | View full cache | Visit Website September 2006 PDF Course Materials - Volume 9, Number 9High-Dose Atorvastatin Reduces Stroke Risk After Recent Stroke or Transient Ischemic Attack: The SPARCL Trial; Diabetes Might be a High-Risk Feature for Mortality With Acute Coronary Syndrome; Overweight and Obesity Are Both Linked to Increased Mortality in Midlife Adults; Commentary by David L. Bronson, MD, FACPListen | Listen in your iPhone | Download | View full cache | Visit Website August 2006 PDF Course Materials - Volume 9, Number 8Management of Hyperglycemia in Type 2 Diabetes: A Consensus Statement From the ADA and EASD; Metabolic Syndrome No More Predictive of CV Mortality Than Its Individual Components; Sibutramine Treatment Added to Behavioral Therapy Improves Metabolic Risk Factors in Obese Adolescents; Commentary by Silvio E. Inzucchi, MDListen | Listen in your iPhone | Download | View full cache | Visit Website July 2006 PDF Course Materials - Volume 9, Number 7The impact of greater glycemic control after AMI in patients without diabetes; The link of retinol-binding protein 4 to increased IR and CV risk; Higher risks associated with an IFG 110 vs IFG 100; Commentary by Henry N. Ginsberg, MDListen | Listen in your iPhone | Download | View full cache | Visit Website June 2006 PDF Course Materials - Volume 9, Number 6Possible Increased Risk of Adverse Cardiovascular Outcomes With Sulfonylureas in Type 2 Diabetes; Regression of Coronary Atherosclerosis With Intensive Statin Therapy: The ASTEROID Trial; High-Fiber, Low-Fat Diet Reduces Risk for Type 2 Diabetes; Commentary by Saul Genuth, MDListen | Listen in your iPhone | Download | View full cache | Visit Website December 2007 Audio - Volume 10, Number 12Using Torcetrapib to Raise HDL-C in Patients at High CV Risk Commentary from Burton E. Sobel, MD; Overweight in Childhood Increases CHD Risk as Adults; Control in Patients with Non–Insulin Treated DiabetesListen | Listen in your iPhone | Download | View full cache | Visit Website December 2007 PDF Course Materials - Volume 10, Number 12Using Torcetrapib to Raise HDL-C in Patients at High CV Risk Commentary from Burton E. Sobel, MD; Overweight in Childhood Increases CHD Risk as Adults; Control in Patients with Non–Insulin Treated DiabetesListen | Listen in your iPhone | Download | View full cache | Visit Website November 2007 Audio - Volume 10, Number 11Low HDL Cholesterol Levels and Risk of CV Events
Commentary by Saul Genuth, MD; Prevalence and Treatment of Low HDL-C in Patients With Type 2 Diabetes; Utility of A1C Screening for DiabetesListen | Listen in your iPhone | Download | View full cache | Visit Website November 2007 PDF Course Materials - Volume 10, Number 11Low HDL Cholesterol Levels and Risk of CV Events
Commentary by Saul Genuth, MD; Prevalence and Treatment of Low HDL-C in Patients With Type 2 Diabetes; Utility of A1C Screening for DiabetesListen | Listen in your iPhone | Download | View full cache | Visit Website October 2007 PDF Course Materials - Volume 10, Number 10The Association of Nonalcoholic Fatty Liver Disease With CVD Event Risk in Patients With Type 2 Diabetes
Commentary by Silvio E. Inzucchi, MD; Nonfasting Triglycerides Associated With Increased Risk of Cardiovascular Events; Higher Mortality in Diabetes Following Acute Coronary SyndromesListen | Listen in your iPhone | Download | View full cache | Visit Website September 2007 PDF Course Materials - Volume 10, Number 9An Analysis of Thiazolidinediones and Heart Failure; Mortality Rates Reduced in Men but Not in Women With Diabetes, 1971 to 2000; Decreased Myocardial Reperfusion in Patients With Diabetes Undergoing Percutaneous Coronary Intervention for ST-Segment Elevation Acute Myocardial Infarction: the EMERALD Trial; Commentary by James W. Reed, MDListen | Listen in your iPhone | Download | View full cache | Visit Website October 2007 Audio - Volume 10, Number 10The Association of Nonalcoholic Fatty Liver Disease With CVD Event Risk in Patients With Type 2 Diabetes
Commentary by Silvio E. Inzucchi, MD; Nonfasting Triglycerides Associated With Increased Risk of Cardiovascular Events; Higher Mortality in Diabetes Following Acute Coronary SyndromesListen | Listen in your iPhone | Download | View full cache | Visit Website September 2007 Audio - Volume 10, Number 9An Analysis of Thiazolidinediones and Heart Failure; Mortality Rates Reduced in Men but Not in Women With Diabetes, 1971 to 2000; Decreased Myocardial Reperfusion in Patients With Diabetes Undergoing Percutaneous Coronary Intervention for ST-Segment Elevation Acute Myocardial Infarction: the EMERALD Trial; Commentary by James W. Reed, MDListen | Listen in your iPhone | Download | View full cache | Visit Website August 2007 Audio - Volume 10, Number 8Diabetic Retinopathy and the Risk of Coronary Heart Disease: The ARIC Study; Incretin Levels and Effect Are Markedly Enhanced 1 Month After Roux-en-Y Gastric Bypass Surgery in Obese Patients With Type 2 Diabetes; No Impact on All-Cause Mortality With Various Oral Antihyperglycemic Agents Relative to Sulfonylurea; Commentary by Bernard Zinman, MDListen | Listen in your iPhone | Download | View full cache | Visit Website July 2007 Audio - Volume 10, Number 7Intentional Weight Loss Improves Cardiovascular Disease Risk Factors in Type 2 Diabetes; Very Low Birth Weight Is Associated With Impaired Glucose
Regulation in Young Adults; Commentary by Vivian A. Fonseca, MD; Type 2 Diabetes and Life Expectancy With and Without Cardiovascular DiseaseListen | Listen in your iPhone | Download | View full cache | Visit Website June 2007 Audio - Volume 10, Number 6Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death From Cardiovascular Causes; Topiramate Controlled Release in the Treatment of Obese Patients With Type 2 Diabetes; An Interim Analysis of Cardiovascular Outcomes With Rosiglitazone: The RECORD Trial; Commentary by Burton E. Sobel, MD and John B. Buse, MD, PhDListen | Listen in your iPhone | Download | View full cache | Visit Website May 2007 Audio - Volume 10, Number 5Addition of Exenatide to Thiazolidinedione Therapy Improves Glycemic Control and Reduces Body Weight in Patients With Type 2 Diabetes; Disparities in Insulin Resistance and Risk Factors for Type 2 Diabetes and Cardiovascular Disease in Moderately Obese Individuals; Traditional Obesity Theshold Might Be Too High for Non-European Populations; Commentary by Thomas A. Buchanan, MDListen | Listen in your iPhone | Download | View full cache | Visit Website April 2007 Audio - Volume 10, Number 4American Diabetes Association Consensus Statement on IFG and IGT; Rosuvastatin Decreases Progression of Carotid Intima-Media Thickness in Patients With Subclinical Atherosclerosis but Does Not Induce Regression; Boric Acid Vaginal Suppositories Are More Effective Than Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis; Commentary by Saul Genuth, MDListen | Listen in your iPhone | Download | View full cache | Visit Website February 2007 Audio - Volume 10, Number 2Sitagliptin Improves Glycemic Control in Patients With Type 2 Diabetes Not Controlled With Either Metformin or Pioglitazone: The Results of Two Studies; Intensive Lipid-Lowering Therapy for Acute Coronary Syndrome and Diabetes Effect of Folic Acid Supplementation on Risk of CVD. Commentary by James W. Reed, MDListen | Listen in your iPhone | Download | View full cache | Visit Website March 2007 Audio - Volume 10, Number 3Rate of Progression From Impaired Fasting Glucose to Type 2 Diabetes Effects of Pioglitazone on Risk of Stroke in Patients WithType 2 Diabetes Stages in the Evolution of Type 2 Diabetes: Loss of Postprandial Glycemic Control Followed by Nocturnal Fasting HyperglycemiaCommentary by David L. Bronson, MDListen | Listen in your iPhone | Download | View full cache | Visit Website January 2007 Audio - Volume 10, Number 1AHA/ADA Statement on Primary Prevention of CVD in People With Type 2 Diabetes ADA Standards of Medical Care in Diabetes—2007 NDEI®Upcoming CME/CE Live Events Commentary by Henry N. Ginsberg, MDListen | Listen in your iPhone | Download | View full cache | Visit Website December 2006 Audio - Volume 9, Number 12Comparing Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Therapy: The ADOPT Study; Fasting Glucose Levels and Incident Type 2 Diabetes in Older Adults Without Diabetes Receiving Antihypertensive Treatment; Asymptomatic Bacteriuria in Women With Type 2 Diabetes; Commentary by Vivian Fonseca, MDListen | Listen in your iPhone | Download | View full cache | Visit Website November 2006 Audio - Volume 9, Number 11Effect of Pioglitazone vs Glimepiride on Carotid IMT in Type 2 Diabetes: The CHICAGO Trial Efficacy of Metformin Therapy in Nonobese Persons With Type 2 Diabetes Addition of Glargine Insulin or Rosiglitazone to Metformin Plus Sulfonylurea for Poorly Controlled Type 2 Diabetes Commentary by Bernard Zinman, MDCMListen | Listen in your iPhone | Download | View full cache | Visit Website October 2006 Audio - Volume 9, Number 10Rosiglitazone Plus Lifestyle Changes Reduce the Incidence of Type 2 Diabetes and Increase Regression to Normoglycemia in Patients at High Risk: the DREAM Trial; Inhaled Human Insulin vs Glyburide as Adjunctive Therapy for Type 2 Diabetes; Different Lifestyles Create Significantly Different Prevalences of Type 2 Diabetes in Pima Indians in the US and Mexico; Commentaries by Thomas A. Buchanan, MD and Mayer B. Davidson, MDListen | Listen in your iPhone | Download | View full cache | Visit Website September 2006 Audio - Volume 9, Number 9High-Dose Atorvastatin Reduces Stroke Risk After Recent Stroke or Transient Ischemic Attack: The SPARCL Trial; Diabetes Might be a High-Risk Feature for Mortality With Acute Coronary Syndrome; Overweight and Obesity Are Both Linked to Increased Mortality in Midlife Adults; Commentary by David L. Bronson, MD, FACPListen | Listen in your iPhone | Download | View full cache | Visit Website August 2006 Audio - Volume 9, Number 8Management of Hyperglycemia in Type 2 Diabetes: A Consensus Statement From the ADA and EASD; Metabolic Syndrome No More Predictive of CV Mortality Than Its Individual Components; Sibutramine Treatment Added to Behavioral Therapy Improves Metabolic Risk Factors in Obese Adolescents; Commentary by Silvio E. Inzucchi, MDListen | Listen in your iPhone | Download | View full cache | Visit Website July 2006 Audio - Volume 9, Number 7The impact of greater glycemic control after AMI in patients without diabetes; The link of retinol-binding protein 4 to increased IR and CV risk; Higher risks associated with an IFG 110 vs IFG 100; Commentary by Henry N. Ginsberg, MDListen | Listen in your iPhone | Download | View full cache | Visit Website June 2006 Audio - Volume 9, Number 6Possible Increased Risk of Adverse Cardiovascular Outcomes With Sulfonylureas in Type 2 Diabetes; Regression of Coronary Atherosclerosis With Intensive Statin Therapy: The ASTEROID Trial; High-Fiber, Low-Fat Diet Reduces Risk for Type 2 Diabetes; Commentary by Saul Genuth, MDListen | Listen in your iPhone | Download | View full cache | Visit Website May 2006 Audio - Volume 9, Number 5Folic Acid and Vitamin B6 and B12 Supplementation Lower Homocysteine Levels but Not Cardiovascular Risks; Acute Glucose Fluctuation Is a Greater Activator of Oxidative Stress Than Sustained Chronic Hyperglycemia in Type 2 Diabetes; Impact of Moderate Alcohol Consumption on Coronary Atherosclerosis; Commentary by Vivian A. Fonseca, MDListen | Listen in your iPhone | Download | View full cache | Visit Website April 2006 Audio - Volume 9, Number 4Is Measuring Waist Circumference a Better Indicator of Insulin Resistance Than Other ATP-III Metabolic Syndrome Components?; Differences of Endogenous Sex Hormones in Men and Women Linked to Type 2 Diabetes RiskListen | Listen in your iPhone | Download | View full cache | Visit Website May 2006 PDF Course Materials - Volume 9, Number 5Folic Acid and Vitamin B6 and B12 Supplementation Lower Homocysteine Levels but Not Cardiovascular Risks; Acute Glucose Fluctuation Is a Greater Activator of Oxidative Stress Than Sustained Chronic Hyperglycemia in Type 2 Diabetes; Impact of Moderate Alcohol Consumption on Coronary Atherosclerosis; Commentary by Vivian A. Fonseca, MDListen | Listen in your iPhone | Download | View full cache | Visit Website April 2006 PDF Course Materials - Volume 9, Number 4Is Measuring Waist Circumference a Better Indicator of Insulin Resistance Than Other ATP-III Metabolic Syndrome Components?; Differences of Endogenous Sex Hormones in Men and Women Linked to Type 2 Diabetes RiskListen | Listen in your iPhone | Download | View full cache | Visit Website
|